APYX vs. GHC

In the year-to-date period, APYX achieves a -9.12% return, which is significantly lower than GHC's 7.80% return. Over the past 10 years, APYX has underperformed GHC with an annualized return of -8.94%, while GHC has yielded a comparatively higher 6.03% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Graham Holdings Company (GHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current APYX Sharpe Ratio is -0.50, which is lower than the GHC Sharpe Ratio of 0.99. The chart below compares the historical Sharpe Ratios of APYX and GHC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

APYX has not paid dividends to shareholders, while GHC's dividend yield for the trailing twelve months is around 0.74%.

The maximum APYX drawdown since its inception was -94.20%, which is greater than GHC's maximum drawdown of -67.54%. Use the drawdown chart below to compare losses from any high point for APYX and GHC. For additional features, visit the drawdowns tool.

Apyx Medical Corporation (APYX) has a higher volatility of 19.96% compared to Graham Holdings Company (GHC) at 6.86%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than GHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Apyx Medical Corporation and Graham Holdings Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.